Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Florent

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Gut|February 1, 1994
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesC Cellier, T Sahmoud, E Froguel, et al.
Gut|April 1, 1988
Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit timeJ C Rambaud, R Jian, B Flourié, et al.
Journal of Medicinal Chemistry|May 9, 1997
Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogsD R Adams, C Perez, M Maillard, et al.
Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.
Gastroenterology|May 1, 1992
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires DigestivesB Landi, T N Anh, A Cortot, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
Chronic gastritis: prevalence in the French population. CIRIGF Potet, C Florent, E Benhamou, et al.
Gut|December 1, 1995
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesT Sahmoud, G Hoctin-Boes, R Modigliani, et al.
Anti-Cancer Drug Design|July 16, 1999
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapyS Desbene, H D Van, S Michel, et al.
Gastroenterology|February 1, 1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)J P Gendre, J Y Mary, C Florent, et al.
Annales De Gastroenterologie Et D'Hepatologie|October 1, 1993
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]J P Gendre, J Y Mary, C Florent, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Gut|February 1, 1994
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesC Cellier, T Sahmoud, E Froguel, et al.
Gut|April 1, 1988
Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit timeJ C Rambaud, R Jian, B Flourié, et al.
Journal of Medicinal Chemistry|May 9, 1997
Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogsD R Adams, C Perez, M Maillard, et al.
Anti-Cancer Drug Design|September 1, 1995
Prodrugs of anthracycline antibiotics suited for tumor-specific activationM Azoulay, J C Florent, C Monneret, et al.
Gastroenterology|May 1, 1992
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires DigestivesB Landi, T N Anh, A Cortot, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
Chronic gastritis: prevalence in the French population. CIRIGF Potet, C Florent, E Benhamou, et al.
Gut|December 1, 1995
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesT Sahmoud, G Hoctin-Boes, R Modigliani, et al.
Anti-Cancer Drug Design|July 16, 1999
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapyS Desbene, H D Van, S Michel, et al.
Gastroenterology|February 1, 1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)J P Gendre, J Y Mary, C Florent, et al.
Annales De Gastroenterologie Et D'Hepatologie|October 1, 1993
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]J P Gendre, J Y Mary, C Florent, et al.
Pageof 12